![David Colpman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Colpman
Directeur/Membre du Conseil chez
ELUTIA INC.
Fortune : 26 869 $ au 31/08/2026
Profil
David Colpman is currently an Independent Director at Elutia, Inc. since 2022.
Holds director positions at HighCape Capital Acquisition Corp.
II and Oak Hill Bio Corp.
since 2022.
Member of the Royal Pharmaceutical Society of Great Britain.
Advisor at HighCape Partners Management LLC and Science Creates Ventures LLP.
Formerly Director at HRA Pharma Development SARL from 2016 to 2022.
Non-Executive Director at Organon R&D Finland Oy.
Independent Director at HighCape Capital Acquisition Corp.
from 2020 to 2021.
Independent Director at Orexo AB from 2015 to 2022.
Senior Vice President at Shire Plc from 2012 to 2014.
Principal at GlaxoWellcome from 1997 to 1999.
Principal at Purdue Pharma (Canada) in 2015.
Partner at Colpman Consulting Ltd. from 2014 to 2020.
Completed undergraduate degree at the University of Portsmouth in 1984.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ELUTIA INC CLASS A 0,07 % | 11/06/2026 | 31 098 ( 0,07 % ) | 26 869 $ | 31/08/2026 |
Postes actifs de David Colpman
| Sociétés | Poste | Début |
|---|---|---|
| ELUTIA INC. | Directeur/Membre du Conseil | 20/10/2022 |
Royal Pharmaceutical Society of Great Britain
 Royal Pharmaceutical Society of Great Britain Miscellaneous Commercial ServicesCommercial Services Provides expertise and support to its member pharmacists | Corporate Officer/Principal | - |
HighCape Capital Acquisition Corp. II
 HighCape Capital Acquisition Corp. II Financial ConglomeratesFinance Operates as a blank check company | Directeur/Membre du Conseil | - |
Oak Hill Bio Corp.
 Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology research organization that develops medicines | Directeur/Membre du Conseil | 01/03/2022 |
HighCape Partners Management LLC
 HighCape Partners Management LLC Investment ManagersFinance HighCape Partners invests in companies located in the United States. The firm targets companies operating the fields of commercial and life sciences sectors. It provides financing for growth stage transactions. | Consultant / Advisor | - |
Science Creates Ventures
 Science Creates Ventures Investment ManagersFinance Science Creates Ventures invests in companies located in the United Kingdom. The firm focuses on the technology sector. It provides capital for seed and early stage capital requirements. | Consultant / Advisor | - |
Anciens postes connus de David Colpman
| Sociétés | Poste | Fin |
|---|---|---|
| OREXO AB | Directeur/Membre du Conseil | 01/05/2022 |
HRA Pharma Development SARL
 HRA Pharma Development SARL Pharmaceuticals: MajorHealth Technology Develops medicines and products for women's health and endocrinology | Directeur/Membre du Conseil | 01/04/2022 |
| HIGE CAPI | Directeur/Membre du Conseil | 10/06/2021 |
| ░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de David Colpman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
60
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Royal Pharmaceutical Society of Great Britain
Royal Pharmaceutical Society of Great Britain Miscellaneous Commercial ServicesCommercial Services Provides expertise and support to its member pharmacists | Commercial Services |
GlaxoWellcome /Pharmocology Unit/
 GlaxoWellcome /Pharmocology Unit/ Miscellaneous Commercial ServicesCommercial Services Provides research and development services to the pharmaceutical industry | Commercial Services |
Orexo AB
 Orexo AB Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products | Health Technology |
University of Portsmouth
 University of Portsmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Purdue Pharma (Canada)
 Purdue Pharma (Canada) Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
HRA Pharma Development SARL
HRA Pharma Development SARL Pharmaceuticals: MajorHealth Technology Develops medicines and products for women's health and endocrinology | Health Technology |
HighCape Partners Management LLC
HighCape Partners Management LLC Investment ManagersFinance HighCape Partners invests in companies located in the United States. The firm targets companies operating the fields of commercial and life sciences sectors. It provides financing for growth stage transactions. | Finance |
Forendo Pharma Oy
 Forendo Pharma Oy Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage drug company that develops novel treatments in women’s health | Health Technology |
Colpman Consulting Ltd.
 Colpman Consulting Ltd. Financial ConglomeratesFinance Provides financial advisory service | Finance |
Elutia, Inc.
 Elutia, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops customized tissue products | Health Technology |
HighCape Capital Acquisition Corp.
 HighCape Capital Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
HighCape Capital Acquisition Corp. II
HighCape Capital Acquisition Corp. II Financial ConglomeratesFinance Operates as a blank check company | Finance |
Science Creates Ventures
Science Creates Ventures Investment ManagersFinance Science Creates Ventures invests in companies located in the United Kingdom. The firm focuses on the technology sector. It provides capital for seed and early stage capital requirements. | Finance |
Oak Hill Bio Corp.
Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology research organization that develops medicines | Commercial Services |
